cancer clinical trials in overland park, KS
|
Saint Luke's Hospital - South
Overland Park, Kansas 66213 Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's Hospital - South Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition
|
|
Kansas City Cancer Center, LLC
Overland Park, Kansas 66210 Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
|
|
Kansas City Cancer Centers - Southwest
Overland Park, Kansas 66210 Prostate Cancer
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's South Hospital Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Mucosal Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
|
|
Kansas City Cancer Centers-Southwest
Trial Locations Kansas City Cancer Centers-Southwest Saint Luke's South Hospital Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
|
|
Saint Luke's Hospital - South
Trial Locations Saint Luke's Hospital - South Kansas City Cancer Centers - Southwest Lung Cancer
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's Hospital - South Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Psychosocial Effects of Cancer and Its Treatment
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's Hospital - South Melanoma (Skin)
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's South Hospital Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
|
|
Kansas City Cancer Center KCCC- South (2)
Overland Park, Kansas 66210 HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's Hospital - South Colorectal Cancer, Precancerous Condition
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's South Hospital Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
|
|
Kansas City Cancer Center, LLC
Overland Park, Kansas 66210 Relapsed Multiple Myeloma
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Overland Park, Kansas 66210 Head and Neck Cancer
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's South Hospital Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Overland Park, Kansas 66210 Head and Neck Neoplasms
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's Hospital - South Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's Hospital - South Kansas City Cancer Centers - Southwest Kidney Cancer
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's Hospital - South Kansas City Cancer Centers - Southwest Colorectal Cancer
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Overland Park, Kansas 66210 Non Small Cell Lung Cancer
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's South Hospital Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
|
|
Saint Luke's South Hospital
Overland Park, Kansas 66213 Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
|
|
Kansas City Cancer Centers - Southwest
Overland Park, Kansas 66210 Prostate Cancer
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Overland Park, Kansas 66210 Stomach Cancer, Esophageal Cancer
|
|
Kansas City Cancer Centers-Southwest
Overland Park, Kansas 66210 Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
|
|
Kansas City Cancer Centers-Southwest
Overland Park, Kansas 66210 Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
|
|
Menorah Medical Center
Trial Locations Menorah Medical Center Saint Luke's South Hospital Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
|
